Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


JAMA garlic/cholesterol study

This article was originally published in The Tan Sheet

Executive Summary

Finds garlic had no effect on cholesterol levels, cholesterol absorption or cholesterol synthesis, Heiner Berthold, MD/PhD, University of Bonn, et al., report in the June 17 Journal of the American Medical Association. The three endpoints were "virtually unchanged" after the 12-week study, leading the researchers to conclude garlic cannot be recommended for treatment of hypercholesterolemia on the basis of the trial. During the 12-week, randomized, double-blind, placebo-controlled, cross-over study, 25 moderate hypercholesterolemic patients (average total cholesterol of 291 mg/dL) received either 5 mg enteric-coated steam-distilled garlic oil (Tegra, Hermes Arzneimittel, Munich) or a garlic-flavored placebo. CRN and Lichtwer Pharma (marketer of Kwai garlic) issued statements challenging the study's importance in light of other evidence; both note the study used garlic oil, not powdered garlic, which they say is more effective...





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts